Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Beauty Health (SKIN) over the last 6 years, with Q3 2025 value amounting to $219.4 million.

  • Beauty Health's Cash & Equivalents fell 3886.82% to $219.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $219.4 million, marking a year-over-year decrease of 3886.82%. This contributed to the annual value of $370.1 million for FY2024, which is 2924.56% down from last year.
  • Latest data reveals that Beauty Health reported Cash & Equivalents of $219.4 million as of Q3 2025, which was down 3886.82% from $212.0 million recorded in Q2 2025.
  • Beauty Health's 5-year Cash & Equivalents high stood at $901.9 million for Q4 2021, and its period low was $2.8 million during Q1 2021.
  • For the 5-year period, Beauty Health's Cash & Equivalents averaged around $481.5 million, with its median value being $523.0 million (2023).
  • In the last 5 years, Beauty Health's Cash & Equivalents skyrocketed by 287438800.0% in 2021 and then crashed by 3934.96% in 2025.
  • Quarter analysis of 5 years shows Beauty Health's Cash & Equivalents stood at $901.9 million in 2021, then tumbled by 37.0% to $568.2 million in 2022, then dropped by 7.95% to $523.0 million in 2023, then decreased by 29.25% to $370.1 million in 2024, then crashed by 40.71% to $219.4 million in 2025.
  • Its Cash & Equivalents was $219.4 million in Q3 2025, compared to $212.0 million in Q2 2025 and $373.0 million in Q1 2025.